Literature DB >> 1927941

Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989)

T J Montague1, R M Ikuta, R Y Wong, K S Bay, K K Teo, N J Davies.   

Abstract

To further evaluate contemporary risk and practice patterns in acute myocardial infarction (AMI), 402 consecutive patients with AMI between July 1, 1988, and June 30, 1989 were studied. The clinical investigations, medical therapy and outcome of patients aged greater than or equal to 70 years (n = 132; group 1) were compared with patients aged less than 70 years (n = 270; group 2). In group 1, 20% of patients had no typical cardiac pain versus 6% in group 2 (p less than 0.01). History of previous AMI, Q-wave AMI and peak creatine kinase were not different in the 2 groups. In-hospital mortality was markedly higher in group 1 (27%) than in group 2 (8%), p less than 0.01. Multivariate analysis revealed previous AMI, presentation without typical pain and age greater than or equal to 70 years to be independently associated with the greatest relative risk. Post-AMI exercise testing, ejection fraction calculations and coronary angiography were all performed less often (p less than 0.01); proven effective medical therapies, including thrombolysis, beta blockers, acetylsalicylic acid and nitrates were all used less frequently (p less than 0.01). The very high mortality and less aggressive management of elderly patients with AMI confirm similar data from our 1987 AMI patient cohort and other recently reported AMI patient outcome analyses. However, it remains uncertain why older patients with AMI are investigated and treated differently from younger patients. Further studies are warranted.

Entities:  

Mesh:

Year:  1991        PMID: 1927941     DOI: 10.1016/0002-9149(91)90397-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Management of acute myocardial infarction in the elderly.

Authors:  D E Forman; M W Rich
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 2.  Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications.

Authors:  W D Bradford; J Chen; H M Krumholz
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

Review 3.  Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease.

Authors:  R W Jansen; J H Gurwitz
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

Review 4.  Optimising thrombolytic therapy in elderly patients with acute myocardial infarction.

Authors:  M Verstraete; D Collen
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

5.  Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.

Authors:  D McCormick; J H Gurwitz; J Savageau; J Yarzebski; J M Gore; R J Goldberg
Journal:  J Gen Intern Med       Date:  1999-02       Impact factor: 5.128

Review 6.  Postinfarction use of beta-blockers in elderly patients.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

7.  Changes in rates of beta-blocker use in community hospital patients with acute myocardial infarction.

Authors:  Adesuwa B Olomu; Ralph E Watson; Azfar-e-Alam Siddiqi; Francesca C Dwamena; Barbara A McIntosh; Peter Vasilenko; Joel Kupersmith; Margaret M Holmes-Rovner
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

Review 8.  Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike?

Authors:  Bijesh P Maroo; Carl J Lavie; Richard V Milani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Lumbar spine surgery and mortality among Medicare beneficiaries, 1986.

Authors:  N B Oldridge; Z Yuan; J E Stoll; A R Rimm
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

10.  Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction.

Authors:  S H Sial; M Malone; J L Freeman; R Battiola; J Nachodsky; J S Goodwin
Journal:  J Gen Intern Med       Date:  1994-11       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.